A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer
Clinical trial NCT03373006 · COMPLETED
Trial details
- NCT number
- NCT03373006
- Sponsor
- HALO Diagnostics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2020-01-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.